Have a personal or library account? Click to login
Importance of Inflammatory Markers in the Evolution of Parkinson Disease Patients with Device Aided Therapies (Mini-Series of Cases) Cover

Importance of Inflammatory Markers in the Evolution of Parkinson Disease Patients with Device Aided Therapies (Mini-Series of Cases)

ARS Medica Tomitana
Volume 30 (2024): Issue 2 (May 2024)
By: Cristina Ramona Tase,  Any Axelerad and  Andra-Iulia Suceveanu  
Open Access
|Aug 2024

Authors

Cristina Ramona Tase

tasecristinaramona@yahoo.com

Neurology Department, Clinical County Emergency Hospital of Constanta, „Sf. Apostol Andrei”, Romania

Any Axelerad

Neurology Department, Clinical County Emergency Hospital of Constanta, „Sf. Apostol Andrei”, Romania
Faculty of Medicine, Ovidius University, Constanta, Romania

Andra-Iulia Suceveanu

Gastroenterology Department, Clinical County Emergency Hospital of Constanta, „Sf. Apostol Andrei”, Romania
Faculty of Medicine, Ovidius University, Constanta, Romania
DOI: https://doi.org/10.2478/arsm-2024-0009 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Journal RSS Feed
Language: English
Page range: 61 - 63
Published on: Aug 21, 2024
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
parkinson disease,
inflammatory markers,
fecal calprotectin
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2024 Cristina Ramona Tase, Any Axelerad, Andra-Iulia Suceveanu, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 30 (2024): Issue 2 (May 2024)Next article